204 research outputs found

    Cancer and Stem Cell Biology: How Tightly Intertwined?

    Get PDF
    Ever since the discovery of cancer stem cells in leukemia and, more recently, in solid tumors, enormous attention has been paid to the apparent stem cell nature of cancer. These concepts were the focus of the “Stem Cells and Cancer” symposium held recently at the University of California, San Francisco, and the inspiration for this overview of current research and important questions emerging in this area

    Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer’s hierarchy.

    Get PDF
    ABSTRACT Neuro-oncology research has rediscovered a complexity of nervous system cancers through the incorporation of cellular heterogeneity into tumor models with cellular subsets displaying stem-cell characteristics. Self-renewing cancer stem cells (CSCs) can propagate tumors and yield nontumorigenic tumor bulk cells that display a more differentiated phenotype. The ability to prospectively isolate and interrogate CSCs is defining molecular mechanisms responsible for the tumor maintenance and growth. The clinical relevance of CSCs has been supported by their resistance to cytotoxic therapies and their promotion of tumor angiogenesis. Although the field of CSC biology is relatively young, continued elucidation of the features of these cells holds promise for the development of novel patient therapies.

    Bacterial Symbiosis Maintenance in the Asexually Reproducing and Regenerating Flatworm Paracatenula galateia

    Get PDF
    Bacteriocytes set the stage for some of the most intimate interactions between animal and bacterial cells. In all bacteriocyte possessing systems studied so far, de novo formation of bacteriocytes occurs only once in the host development, at the time of symbiosis establishment. Here, we present the free-living symbiotic flatworm Paracatenula galateia and its intracellular, sulfur-oxidizing bacteria as a system with previously undescribed strategies of bacteriocyte formation and bacterial symbiont transmission. Using thymidine analogue S-phase labeling and immunohistochemistry, we show that all somatic cells in adult worms – including bacteriocytes – originate exclusively from aposymbiotic stem cells (neoblasts). The continued bacteriocyte formation from aposymbiotic stem cells in adult animals represents a previously undescribed strategy of symbiosis maintenance and makes P. galateia a unique system to study bacteriocyte differentiation and development. We also provide morphological and immunohistochemical evidence that P. galateia reproduces by asexual fragmentation and regeneration (paratomy) and, thereby, vertically transmits numerous symbiont-containing bacteriocytes to its asexual progeny. Our data support the earlier reported hypothesis that the symbiont population is subjected to reduced bottleneck effects. This would justify both the codiversification between Paracatenula hosts and their Candidatus Riegeria symbionts, and the slow evolutionary rates observed for several symbiont genes

    SNL evaluation of Gigabit Passive Optical Networks (GPON).

    Get PDF
    Gigabit Passive Optical Networks (GPON) is a networking technology which offers the potential to provide significant cost savings to Sandia National Laboratories in the area of network operations. However, a large scale GPON deployment requires a significant investment in equipment and infrastructure. Before a large scale GPON system was acquired and built, a small GPON system manufactured by Motorola was acquired and tested. The testing performed was to determine the suitability of GPON for use at SNL. This report documents that testing. This report presents test results of GPON system consisting of Motorola and Juniper equipment. The GPON system was tested in areas of data throughput, video conferencing, VOIP, security, and operations and management. The GPON system performed well in almost all areas. GPON will not meet the needs of the low percentage of users requiring a true 1-10 Gbps network connection. GPON will also most likely not meet the need of some servers requiring dedicated throughput of 1-10 Gbps. Because of that, there will be some legacy network connections that must remain. If these legacy network connections can not be reduced to a bare minimum and possibly consolidated to a few locations, any cost savings gained by switching to GPON will be negated by maintaining two networks. A contract has been recently awarded for new GPON equipment with larger buffers. This equipment should improve performance and further reduce the need for legacy network connections. Because GPON has fewer components than a typical hierarchical network, it should be easier to manage. For the system tested, the management was performed by using the AXSVison client. Access to the client must be tightly controlled, because if client/server communications are compromised, security will be an issue. As with any network, the reliability of individual components will determine overall system reliability. There were no failures with the routers, OLT, or Sun Workstation Management platform. There were however four ONTs that failed. Because of the small sample size of 64, and the fact that some of the ONTs were used units, no conclusions can be made. However, ONT reliability is an area of concern. Access to the fiber plant that GPON requires must be tightly controlled and all changes documented. The undocumented changes that were performed in the GPON test lab demonstrated the need for tight control and documentation. In summary, GPON should be able to meet the needs of most network users at Sandia National Laboratories. Because it supports voice, video, and data, it positions Sandia National Laboratories to deploy these services to the desktop. For the majority of corporate network users at Sandia National Laboratories GPON should be a suitable replacement for the legacy network

    macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma

    Get PDF
    Self-renewal is a crucial property of glioblastoma cells that is enabled by the choreographed functions of chromatin regulators and transcription factors. Identifying targetable epigenetic mechanisms of self-renewal could therefore represent an important step toward developing effective treatments for this universally lethal cancer. Here we uncover an epigenetic axis of self-renewal mediated by the histone variant macroH2A2. With omics and functional assays deploying patient-derived in vitro and in vivo models, we show that macroH2A2 shapes chromatin accessibility at enhancer elements to antagonize transcriptional programs of self-renewal. macroH2A2 also sensitizes cells to small molecule-mediated cell death via activation of a viral mimicry response. Consistent with these results, our analyses of clinical cohorts indicate that high transcriptional levels of this histone variant are associated with better prognosis of high-grade glioma patients. Our results reveal a targetable epigenetic mechanism of self-renewal controlled by macroH2A2 and suggest additional treatment approaches for glioblastoma patients

    The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants

    Get PDF
    Multiple independent genomic profiling efforts have recently identified clinically and molecularly distinct subgroups of ependymoma arising from all three anatomic compartments of the central nervous system (supratentorial brain, posterior fossa, and spinal cord). These advances motivated a consensus meeting to discuss: (1) the utility of current histologic grading criteria, (2) the integration of molecular-based stratification schemes in future clinical trials for patients with ependymoma and (3) current therapy in the context of molecular subgroups. Discussion at the meeting generated a series of consensus statements and recommendations from the attendees, which comment on the prognostic evaluation and treatment decisions of patients with intracranial ependymoma (WHO Grade II/III) based on the knowledge of its molecular subgroups. The major consensus among attendees was reached that treatment decisions for ependymoma (outside of clinical trials) should not be based on grading (II vs III). Supratentorial and posterior fossa ependymomas are distinct diseases, although the impact on therapy is still evolving. Molecular subgrouping should be part of all clinical trials henceforth

    CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity

    Get PDF
    Amplification of the C19MC oncogenic miRNA cluster and high LIN28 expression has been linked to a distinctly aggressive group of cerebral CNS-PNETs (group 1 CNS-PNETs) arising in young children. In this study, we sought to evaluate the diagnostic specificity of C19MC and LIN28, and the clinical and biological spectra of C19MC amplified and/or LIN28+ CNS-PNETs. We interrogated 450 pediatric brain tumors using FISH and IHC analyses and demonstrate that C19MC alteration is restricted to a sub-group of CNS-PNETs with high LIN28 expression; however, LIN28 immunopositivity was not exclusive to CNS-PNETs but was also detected in a proportion of other malignant pediatric brain tumors including rhabdoid brain tumors and malignant gliomas. C19MC amplified/LIN28+ group 1 CNS-PNETs arose predominantly in children <4 years old; a majority arose in the cerebrum but 24 % (13/54) of tumors had extra-cerebral origins. Notably, group 1 CNS-PNETs encompassed several histologic classes including embryonal tumor with abundant neuropil and true rosettes (ETANTR), medulloepithelioma, ependymoblastoma and CNS-PNETs with variable differentiation. Strikingly, gene expression and methylation profiling analyses revealed a common molecular signature enriched for primitive neural features, high LIN28/LIN28B and DNMT3B expression for all group 1 CNS-PNETs regardless of location or tumor histology. Our collective findings suggest that current known histologic categories of CNS-PNETs which include ETANTRs, medulloepitheliomas, ependymoblastomas in various CNS locations, comprise a common molecular and diagnostic entity and identify inhibitors of the LIN28/let7/PI3K/mTOR axis and DNMT3B as promising therapeutics for this distinct histogenetic entity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00401-014-1291-1) contains supplementary material, which is available to authorized users
    corecore